Invivyd Files 8-K: Corporate Info Update, Nasdaq Listing Confirmed

Ticker: IVVD · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1832038

Invivyd, INC. 8-K Filing Summary
FieldDetail
CompanyInvivyd, INC. (IVVD)
Form Type8-K
Filed DateJan 8, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: corporate-governance, administrative, regulatory-filing

TL;DR

**Invivyd filed a routine 8-K, just updating corporate info and confirming its Nasdaq listing.**

AI Summary

Invivyd, Inc. (formerly Adagio Therapeutics, Inc.) filed an 8-K on January 8, 2024, to update its corporate information, including its current address at 1601 Trapelo Road, Suite 178, Waltham, MA 02451, and confirm its trading symbol as IVVD on The Nasdaq Stock Market LLC. This filing is largely administrative, indicating no major operational or financial shifts. For investors, this means the company is maintaining its regulatory compliance and there are no immediate red flags regarding its corporate structure or listing status, which is a neutral but stable signal.

Why It Matters

This filing is primarily administrative, confirming Invivyd's current corporate details and Nasdaq listing, which reassures investors of its ongoing regulatory compliance without signaling any new strategic developments.

Risk Assessment

Risk Level: low — This 8-K is a routine administrative filing with no material changes to the company's operations or financial health, indicating low risk.

Analyst Insight

A smart investor would note this as a routine compliance filing, indicating no immediate catalysts or red flags. It's a good reminder to check for more substantive filings like 10-Qs or 10-Ks for actual business performance updates.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant as specified in its charter is Invivyd, Inc.

What was the former name of Invivyd, Inc. and when did the name change occur?

The former name of Invivyd, Inc. was Adagio Therapeutics, Inc., and the date of the name change was November 12, 2020 (20201112).

On which stock exchange is Invivyd, Inc.'s common stock registered and what is its trading symbol?

Invivyd, Inc.'s common stock, with a par value of $0.0001 per share, is registered on The Nasdaq Stock Market LLC under the trading symbol IVVD.

What is the business address and telephone number of Invivyd, Inc.?

The business address of Invivyd, Inc. is 1601 Trapelo Road, Suite 178, Waltham, MA 02451, and its telephone number is (781) 819-0080.

What was the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported in this 8-K filing was January 8, 2024.

Filing Stats: 421 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-01-08 07:12:04

Key Financial Figures

Filing Documents

01

Item 8.01. Other Events. On January 8, 2024, Invivyd, Inc. posted an updated corporate presentation on its website at www.invivyd.com. A copy of the presentation is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated January 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INVIVYD, INC. Date: January 8, 2024 By: /s/ Jill Andersen Jill Andersen Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing